Mukka Proteins Limited (IN:MUKKA)
:MUKKA
Want to see IN:MUKKA full AI Analyst Report?
Top Page
Mukka Proteins Limited
(MUKKA)
Select Model
Select Model
Rating:60Neutral
Price Target:
₹22.50
▼(-5.22% Downside)
Action:ReiteratedDate:11/07/25
Mukka Proteins Limited has strong revenue growth and reasonable valuation, but high leverage and negative cash flows are significant risks. The technical indicators suggest a bearish trend, further impacting the stock's attractiveness.
Positive Factors
Revenue Growth
Sustained double‑digit revenue growth reflects rising demand for fish‑based feed ingredients and expanding processing volumes. A durable top‑line trajectory supports scale benefits and fixed‑cost absorption, positioning the company to invest in capacity or margin improvement if sustained.
Negative Factors
High Leverage
Elevated leverage reduces financial flexibility and increases refinancing and interest burden risk. In a cyclical commodity business, high debt amplifies earnings volatility and can constrain capex, working capital and strategic investments during downturns, raising structural risk over months.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained double‑digit revenue growth reflects rising demand for fish‑based feed ingredients and expanding processing volumes. A durable top‑line trajectory supports scale benefits and fixed‑cost absorption, positioning the company to invest in capacity or margin improvement if sustained.
Read all positive factors
Mukka Proteins Limited (MUKKA) vs. iShares MSCI India ETF (INDA)
Market Cap
₹7.20B
Dividend YieldN/A
Average Volume (3M)40.24K
Price to Earnings (P/E)7.6
Beta (1Y)0.77
Revenue Growth64.53%
EPS Growth-25.13%
CountryIN
Employees414
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.79
Shares Outstanding300,000,000
10 Day Avg. Volume18,929
30 Day Avg. Volume40,240
Financial Highlights & Ratios
PEG Ratio-0.43
Price to Book (P/B)2.25
Price to Sales (P/S)0.98
P/FCF Ratio-7.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Mukka Proteins Limited Business Overview & Revenue Model
Company Description
Mukka Proteins Limited manufactures and sells fish protein products in India. It offers fish meal, oil, and soluble paste. The company also offers insect meal and insect oil. The company's products are used as an ingredient for animal feed, poultr...
How the Company Makes Money
Mukka Proteins makes money by producing and selling fish-based protein ingredients, with revenue primarily generated from (1) sales of fish meal (a high-protein feed ingredient used largely in aquaculture feed formulations) and (2) sales of fish o...
Mukka Proteins Limited Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
65
Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.99B | 10.06B | 13.80B | 11.56B | 7.66B | 5.91B |
| Gross Profit | 2.24B | 2.32B | 1.69B | 1.34B | 799.87M | 439.13M |
| EBITDA | 1.06B | 948.84M | 1.22B | 962.04M | 550.04M | 317.79M |
| Net Income | 434.43M | 464.59M | 700.52M | 440.75M | 242.08M | 89.76M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 10.76B | 9.41B | 5.75B | 3.92B | 3.55B |
| Cash, Cash Equivalents and Short-Term Investments | 30.75M | 30.75M | 944.38M | 265.48M | 180.42M | 41.88M |
| Total Debt | 0.00 | 4.53B | 3.65B | 2.76B | 1.75B | 1.59B |
| Total Liabilities | -4.57B | 6.20B | 5.32B | 4.33B | 2.97B | 2.85B |
| Stockholders Equity | 4.57B | 4.41B | 3.96B | 1.34B | 898.23M | 665.23M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.36B | -1.68B | -737.46M | -63.29M | -112.51M |
| Operating Cash Flow | 0.00 | -1.12B | -1.50B | -655.31M | 1.82M | -5.74M |
| Investing Cash Flow | 0.00 | -349.86M | -475.94M | -53.83M | -142.25M | -136.11M |
| Financing Cash Flow | 0.00 | 555.53M | 2.66B | 746.65M | 158.58M | 93.24M |
Mukka Proteins Limited Technical Analysis
Positive
23.74
Price Trends
22.56
Positive
23.20
Positive
25.29
Negative
Market Momentum
0.35
Negative
65.74
Neutral
94.89
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MUKKA, the sentiment is Positive. The current price of 23.74 is above the 20-day moving average (MA) of 21.46, above the 50-day MA of 22.56, and below the 200-day MA of 25.29, indicating a neutral trend. The MACD of 0.35 indicates Negative momentum. The RSI at 65.74 is Neutral, neither overbought nor oversold. The STOCH value of 94.89 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:MUKKA.
Mukka Proteins Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | ₹7.20B | 7.59 | ― | ― | 64.53% | -25.13% | |
54 Neutral | ₹3.90B | 18.03 | ― | ― | 17.22% | 90.29% | |
54 Neutral | ₹4.41B | 11.19 | ― | ― | -9.43% | ― | |
44 Neutral | ₹360.69M | -5.09 | ― | ― | 204.17% | 3.95% | |
40 Underperform | ₹192.78M | -11.13 | ― | ― | ― | 43.06% |
* Consumer Defensive Sector Average
IN:MUKKA
Mukka Proteins Limited
24.30
-8.25
-25.35%
IN:GOKUL
Gokul Refoils & Solvent Ltd.
40.50
-5.71
-12.36%
IN:GOODRICKE
Goodricke Group Ltd
170.55
-6.95
-3.92%
IN:KOTHARIPRO
Kothari Products Limited.
73.50
1.24
1.72%
IN:SANWARIA
Sanwaria Consumer Ltd
0.49
0.00
0.00%
IN:SRPL
Shree Ram Proteins Ltd.
0.44
-0.58
-56.86%
Mukka Proteins Limited Corporate Events
Mukka Proteins Advances Verra-Listed BSF Waste Project, Wins Approval to Quadruple Capacity
Jan 27, 2026
Mukka Proteins has reached a key milestone in its Black Soldier Fly–based municipal wet-waste processing project in Bengaluru, with its 300 TPD facility now formally listed on the Verra Registry under the Verified Carbon Standard, moving the...
Mukka Proteins Incorporates MPL HRC Ecosolutions LLP for Non-Hazardous Waste Project
Jan 17, 2026
Mukka Proteins Limited has announced the incorporation of MPL HRC Ecosolutions LLP, a new limited liability partnership approved by the Ministry of Corporate Affairs, in which the company holds a 76% capital contribution and profit-sharing stake. ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.